Ravaed by the coronavirus, the planet is now suspended to discover an anti-COVVIV-19 vaccine. And despite the spectacular announcements, no vaccine is, for the time being available.
Among the 200 research projects around the world, 139 are currently tested on animals, 27 are at the clinical stage, tested on humans, and 6 are today the most advanced.
But a Chinese vaccine will probably be available on the market in December 2020, the Chinese press agency Xinhua and local media announced this Monday, August 17, 2020.
The vaccine developed by two companies from the National Pharmaceutical Group China (Sinopharm) was tested in June in the United Arab Emirates, and then be patented. It should be marketed at $ 144 for two doses.
Sinopharm’s president Liu Jingzhen, the company’s COVVI-19 vaccine had entered the third and last stage of clinical trials-in which the effectiveness and safety of a new drug is tested on a large group of people with a disease.
